1356847-98-7
1356847-98-7
Chemical Structure
Trandolapril-d5
Synonym(s): RU44570 d5
- CAS No.: 1356847-98-7
- Formula:C24H29D5N2O5
- Molecular Weight:435.57
IUPAC Name: (2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-(phenyl-d5)butan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylic acid
InChIKey: VXFJYXUZANRPDJ-YFCLCGKXSA-N
SMILES: O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])C)=O)[C@@]3([H])CCCC[C@]3([H])C1)O
Biological Activity: Trandolapril-d5 is a deuterium labeled Trandolapril (RU44570). Trandolapril is an orally active angiotensin converting enzyme (ACE) inhibitor for hypertension and congestive heart failure (CHF)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Trandolapril-d5 | Trandolapril-d5 is a deuterium labeled Trandolapril (RU44570). Trandolapril is an orally active angiotensin converting enzyme (ACE) inhibitor for hypertension and congestive heart failure (CHF). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trandolapril (Standard) | 99.72% | Trandolapril (Standard) is the analytical standard of Trandolapril. This product is intended for research and analytical applications. Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
rac-Trandolapril-d5 | rac-Trandolapril-d5 (rac-RU44570-d5) is deuterium labeled Trandolapril. Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Trandolapril | 99.88% | Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
